GGrantIndex
Sort

21,281 grants matching influenza

Vaccine and Treatment Evaluation Unit at Saint Louis University

$1,189,190
Daniel F. Hoft · Saint Louis University · UM1 · FY2024 · AI

Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site

$1,188,978
Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2022 · AI

Patterning of Transcription Factor Activity in T cells During Influenza Infection

$1,188,848
Rajat Varma · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Innate inflammatory responses during pulmonary infections

$1,188,232
Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

Spirulina oral supplement for enhancing host resilience to virus infection

$1,187,562
Ikhlas Ahmad Khan · University Of Mississippi · U19 · FY2022 · AT

Microarrays and Macaque Influenza Model

$1,187,362
Mount Sinai School Of Medicine Of Nyu · P01 · FY2005 · AI

Structural Biology of Influenza Epitopes

$1,186,925
Audray Harris · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

Point-of-care Diagnosis and Surveillance of Known and Emerging Influenza Viruses

$1,186,565
Timothy M Rose · Seattle Children'S Hospital · R01 · FY2014 · AI

Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage

$1,186,445
Harold A Chapman · University Of California, San Francisco · U01 · FY2022 · HL

Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection

$1,185,932
Sergei V Kotenko · Rbhs-New Jersey Medical School · R01 · FY2016 · AI

Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection

$1,185,932
Sergei V Kotenko · Rbhs-New Jersey Medical School · R01 · FY2015 · AI

Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection

$1,185,617
Sergei V Kotenko · Rbhs-New Jersey Medical School · R01 · FY2014 · AI

MATERNAL IMMUNIZATION TO PREVENT INFANT OTITIS MEDIA

$1,185,349
University Of Minnesota Twin Cities · R01 · FY2004 · DC

Microarrays and Macaque Influenza Model

$1,185,155
Michael G Katze · Icahn School Of Medicine At Mount Sinai · P01 · FY2007 · AI

Diagnostic and Prognostic Biomarkers for Viral Severe Lung Disease

$1,184,414
Ralph S Baric · Columbia University Health Sciences · U19 · FY2014 · AI

Pandemic Influenza Translational Research and Novel Drug Therapy

$1,184,394
Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

Influenza Vaccine Development

$1,183,785
Gary J Nabel · Niaid Extramural Activities · Z01 · FY2007 · AI

Clinical Studies of Vaccines for Pandemic Influenza

$1,181,315
Kanta Subbarao · Niaid Extramural Activities · Z01 · FY2007 · AI

Metabolic and Immunologic Effects of Meditation

$1,181,122
Frederick M Hecht · University Of California, San Francisco · P01 · FY2012 · AT

Spirulina oral supplement for enhancing host resilience to virus infection

$1,178,516
Ikhlas Ahmad Khan · University Of Mississippi · U19 · FY2023 · AT

Immunology of Acute and Chronic Viral Hepatitis

$1,177,571
Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK

A high-sensitivity low-cost multiplexed immunoassay platform based on 2-dimension

$1,177,234
Paul Yager · University Of Washington · R01 · FY2012 · AI

Identification of Metabolic and Immune Deficits in the Aged Population and Their Restoration to Achieve Youthful Anti-Influenza Vaccine Responsiveness

$1,176,696
Wayne A. Marasco · Dana-Farber Cancer Inst · U01 · FY2023 · AI

New Strategies to Prevent Death from Influenza

$1,176,371
Kendall A Smith · Weill Medical Coll Of Cornell Univ · U01 · FY2009 · AI

DYNAMICS AND EVOLUTION OF IMMUNE RESPONSES TO INFLUENZA VIRUSES

$1,176,222
Rustom Noshir Antia · Emory University · U01 · FY2022 · AI